Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
BK virus (BKV) is a polyomavirus that establishes a lifelong persistence in most humans and is a major impediment to success of kidney grafts. The function of the innate immune system in BKV infection and pathology has not been investigated. Here we examine the role of antimicrobial defensins in BKV infection of Vero cells. Our data show that alpha-defensin human neutrophil protein 1 (HNP1) and human alpha-defensin 5 (HD5) inhibit BKV infection by targeting an early event in the viral lifecycle. HD5 treatment of BKV reduced viral attachment to cells, whereas cellular treatment with HD5 did not. Colocalization studies indicated that HD5 interacts directly with BKV. Ultrastructural analysis revealed HD5-induced aggregation of virions. HD5 also inhibited infection of cells by other related polyomaviruses. This is the first study to demonstrate polyomavirus sensitivity to defensins. We also show a novel mechanism whereby HD5 binds to BKV leading to aggregation of virion particles preventing normal virus binding to the cell surface and uptake into cells.
Dugan
Aisling S
AS
Department of Molecular Biology, Brown University, Providence, Rhode Island 02912, USA.
Maginnis
Melissa S
MS
Jordan
Joslynn A
JA
Gasparovic
Megan L
ML
Manley
Kate
K
Page
Rebecca
R
Williams
Geoffrey
G
Porter
Edith
E
O'Hara
Bethany A
BA
Atwood
Walter J
WJ
D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism / Q000494:pharmacology*; D001739:BK Virus / Q000378:metabolism* / Q000648:ultrastructure; D002522:Chlorocebus aethiops; D006801:Humans; D027601:Polyomavirus Infections / Q000378:metabolism* / Q000473:pathology; D014709:Vero Cells; D014771:Virion / Q000378:metabolism / Q000648:ultrastructure; D053586:Virus Internalization / Q000187:drug effects*; D023084:alpha-Defensins / Q000378:metabolism / Q000494:pharmacology*
D000890:Anti-Infective Agents; C500225:DEFA5 protein, human; D023084:alpha-Defensins; C406413:human neutrophil peptide 1
Virology. 2008 Mar 1;372(1):48-55
18031784
Transplantation. 1999 Jan 15;67(1):103-9
9921805
Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):224-31
14561157
Infect Immun. 1997 Jun;65(6):2396-401
9169780
J Natl Cancer Inst. 1975 Apr;54(4):945-50
165302
J Immunol. 2004 Jul 1;173(1):515-20
15210812
Eur J Clin Invest. 2000 Aug;30(8):695-701
10964161
J Allergy Clin Immunol. 2007 Apr;119(4):1022-5
17353034
J Clin Microbiol. 1994 May;32(5):1390-4
8051277
J Med Virol. 2003 Sep;71(1):115-23
12858417
Annu Rev Immunol. 2004;22:181-215
15032578
Transplantation. 2007 Aug 15;84(3):323-30
17700156
Hum Gene Ther. 1999 Apr 10;10(6):957-64
10223729
Pediatr Transplant. 2001 Dec;5(6):398-405
11737764
Mol Immunol. 2003 Nov;40(7):469-75
14568394
FEBS Lett. 2005 Jan 3;579(1):162-6
15620707
FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):59-64
12900056
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94
10795591
J Clin Pathol. 2007 Sep;60(9):1029-34
17412868
J Immunol. 2006 Dec 15;177(12):8658-66
17142766
J Infect Dis. 1999 Jul;180(1):1-9
10353854
J Biol Chem. 2002 Feb 1;277(5):3079-84
11675394
Clin Infect Dis. 1997 Nov;25(5):1134-40
9402371
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18129-34
16330776
Appl Environ Microbiol. 2000 Jan;66(1):238-45
10618230
J Med Virol. 1981;8(2):143-50
6271922
J Am Soc Nephrol. 2002 Aug;13(8):2145-51
12138148
Am J Obstet Gynecol. 1997 Feb;176(2):470-5
9065200
Cell Host Microbe. 2008 Jan 17;3(1):11-9
18191790
J Virol. 2004 Nov;78(21):11583-90
15479799
J Med Virol. 2005 Mar;75(3):447-54
15648074
Science. 1999 Oct 15;286(5439):525-8
10521347
N Engl J Med. 2002 Aug 15;347(7):488-96
12181403
Biochem Biophys Res Commun. 1993 Sep 30;195(3):1336-44
8216266
Transplantation. 1999 Mar 27;67(6):918-22
10199744
J Infect Dis. 1980 Jul;142(1):1-8
6249869
J Clin Invest. 2005 Mar;115(3):765-73
15719067
Am J Obstet Gynecol. 2002 Jul;187(1):137-44
12114901
Nat Immunol. 2005 Oct;6(10):995-1001
16155572
J Biol Chem. 2006 Jul 7;281(27):18787-92
16648135
Virology. 2002 Sep 1;300(2):282-90
12350358
Nephrol Dial Transplant. 2003 Jun;18(6):1190-6
12748354
Science. 2002 Nov 1;298(5595):1025-9
12411706
J Virol. 2005 Nov;79(22):14442-5
16254379
J Leukoc Biol. 2004 Jan;75(1):49-58
14525966
J Virol. 2008 Mar;82(5):2560-4
18094176
Protein Sci. 1994 Sep;3(9):1362-73
7833799
AIDS. 2003 Nov 7;17(16):F39-48
14571200
J Virol. 2006 Apr;80(7):3495-505
16537617
Infect Immun. 1989 Jul;57(7):2021-7
2543629
J Immunol. 2008 May 1;180(9):6176-85
18424739
Proc Natl Acad Sci U S A. 1985 Feb;82(4):1257-61
2983332
Blood. 2000 Nov 1;96(9):3086-93
11049988
Blood. 2007 Apr 1;109(7):2928-35
17132727
J Lab Clin Med. 1993 Aug;122(2):202-7
8340706
J Biol Chem. 2008 Aug 15;283(33):22417-29
18567888
Blood. 1999 Sep 15;94(6):2007-19
10477730
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):651-6
9892688
Clin Diagn Virol. 1995 Mar;3(3):285-95
15566809
J Virol. 1986 Dec;60(3):1068-74
3023659
Clin Infect Dis. 1997 Nov;25(5):1141-2
9402372
AIDS. 1993 Aug;7(8):1129
8397954
Hum Mol Genet. 2005 Jul 15;14(14):2045-52
15944200
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1516-21
16432216
N Engl J Med. 1983 May 19;308(20):1192-6
6302506
J Virol. 2006 Dec;80(24):12079-85
17035332
Antiviral Res. 2007 Nov;76(2):111-23
17655941
J Med Chem. 2007 Jul 12;50(14):3334-9
17569519
Gastroenterology. 2008 Jun;134(7):2049-58
18435932
J Infect Dis. 2005 Aug 15;192(4):658-64
16028135
Infect Immun. 2005 Aug;73(8):4823-33
16040996
Infect Immun. 1997 Nov;65(11):4795-800
9353067
Nat Rev Immunol. 2006 Jun;6(6):447-56
16724099
J Viral Hepat. 2006 Dec;13(12):821-7
17109681
J Infect Dis. 1988 Sep;158(3):563-9
2842404